871 resultados para Predictive Maintenance
Resumo:
This paper addresses the problem of infinite time performance of model predictive controllers applied to constrained nonlinear systems. The total performance is compared with a finite horizon optimal cost to reveal performance limits of closed-loop model predictive control systems. Based on the Principle of Optimality, an upper and a lower bound of the ratio between the total performance and the finite horizon optimal cost are obtained explicitly expressed by the optimization horizon. The results also illustrate, from viewpoint of performance, how model predictive controllers approaches to infinite optimal controllers as the optimization horizon increases.
Resumo:
The introduction of predictive molecular markers has radically enhanced the identification of which patients may benefit from a given treatment. Despite recent controversies, KRAS mutation is currently the most recognized molecular predictive marker in colorectal cancer (CRC), predicting efficacy of anti-epidermal growth factor receptor (anti-EGFR) antibodies. However, other relevant markers have been reported and claimed to identify patients that will benefit from anti-EGFR therapies. This group of markers includes BRAF mutations, PI3KCA mutations, and loss of PTEN expression. Similarly, molecular markers for cytotoxic agents' efficacy also may predict outcome in patients with CRC. This review aims to summarize the most important predictive molecular classifiers in patients with CRC and further discuss any inconsistent or conflicting findings for these molecular classifiers.
Resumo:
The UK’s transport infrastructure is one of the most heavily used in the world. The performance of these networks is critically dependent on the performance of cutting and embankment slopes which make up £20B of the £60B asset value of major highway infrastructure alone. The rail network in particular is also one of the oldest in the world: many of these slopes are suffering high incidents of instability (increasing with time). This paper describes the development of a fundamental understanding of earthwork material and system behaviour, through the systematic integration of research across a range of spatial and temporal scales. Spatially these range from microscopic studies of soil fabric, through elemental materials behaviour to whole slope modelling and monitoring and scaling up to transport networks. Temporally, historical and current weather event sequences are being used to understand and model soil deterioration processes, and climate change scenarios to examine their potential effects on slope performance in futures up to and including the 2080s. The outputs of this research are being mapped onto the different spatial and temporal scales of infrastructure slope asset management to inform the design of new slopes through to changing the way in which investment is made into aging assets. The aim ultimately is to help create a more reliable, cost effective, safer and more resilient transport system.
Resumo:
Colorectal cancer (CRC) is one of the most frequently occurring malignancies worldwide, and the second leading cause of cancer related death in the Western World. Although early stage disease is curable by surgical resection alone, one half of patients with CRC will present with metastatic disease at some stage in the course of their disease. The most active drug in the treatment of CRC is 5-fluorouracil (5-FU) which is used in both the adjuvant and advanced settings. The use of adjuvant therapy is of proven benefit in Stage III CRC, however, its role in Stage II disease is less clear. There is therefore a need to identify those patients with early stage disease who will develop recurrent disease, and who would therefore benefit most from adjuvant treatment. In the advanced setting, the use of irinotecan and oxaliplatin in combination with 5-FU has proven beneficial, with yet further improvements in survival reported with the addition of new targeted agents such as bevacizamab. Despite this, a significant number of patients with advanced disease do not derive any benefit from the chemotherapy they receive, highlighting a need for the development of molecular or genomic markers predictive of response to these chemotherapeutic agents. This review will evaluate the recent advances in pharmacogenomics in CRC, in particular the development of predictive markers of response to chemotherapy. The successful identification of these markers of response will herald an era of personalised treatment, reducing treatment-related toxicity and improving outcome of patients with CRC. -cr 2007 Bentham Science Publishers Ltd.
Resumo:
OBJECTIVES: To improve understanding about the potential underlying biological mechanisms in the link between depression and all-cause mortality and to investigate the role that inflammatory and other cardiovascular risk factors may play in the relationship between depressive symptoms and mortality.
METHODS: Depression and blood-based biological markers were assessed in the Belfast PRIME prospective cohort study (N = 2389 men, aged 50-59 years) in which participants were followed up for 18 years. Depression was measured using the 10-item Welsh Pure Depression Inventory. Inflammation markers (C-reactive protein [CRP], neopterin, interleukin [IL]-1 receptor antagonist [IL-1Ra], and IL-18) and cardiovascular-specific risk factors (N-terminal pro-b-type natriuretic peptide, midregion pro-atrial natriuretic peptide, midregion pro-adrenomedullin, C-terminal pro-endothelin-1 [CT-proET]) were obtained at baseline. We used Cox proportional hazards modeling to examine the association between depression and biological measures in relation to all-cause mortality and explore the mediating effects.
RESULTS: During follow-up, 418 participants died. Higher levels of depressive symptoms were associated with higher levels of CRP, IL-1Ra, and CT-proET. After adjustment for socioeconomic and life-style risk factors, depressive symptoms were significantly associated with all-cause mortality (hazard ratio = 1.10 per scale unit, 95% confidence interval = 1.04-1.16). This association was partly explained by CRP (7.3%) suggesting a minimal mediation effect. IL-1Ra, N-terminal pro-b-type natriuretic peptide, midregion pro-atrial natriuretic peptide, midregion pro-adrenomedullin, and CT-proET contributed marginally to the association between depression and subsequent mortality.
CONCLUSIONS: Inflammatory and cardiovascular risk markers are associated with depression and with increased mortality. However, depression and biological measures show additive effects rather than a pattern of meditation of biological factors in the association between depression and mortality.
Resumo:
Objective: Guidelines recommend the creation of a wrist radiocephalic arteriovenous fistula (RAVF) as initial hemodialysis vascular access. This study explored the potential of preoperative ultrasound vessel measurements to predict AVF failure to mature (FTM) in a cohort of patients with end-stage renal disease in Northern Ireland
.Methods: A retrospective analysis was performed of all patients who had preoperative ultrasound mapping of upper limb blood vessels carried out from August 2011 to December 2014 and whose AVF reached a functional outcome by March 2015.
Results: There were 152 patients (97% white) who had ultrasound mapping andan AVF functional outcome recorded; 80 (54%) had an upper arm AVF created, and 69 (46%) had a RAVF formed. Logistic regression revealed that female gender (odds ratio [OR], 2.5; 95% confidence interval [CI], 1.12-5.55; P = .025), minimum venous diameter (OR, 0.6; 95% CI, 0.39-0.95; P = .029), and RAVF (OR, 0.4; 95% CI, 0.18-0.89; P = .026) were associated with FTM. On subgroup analysis of the RAVF group, RAVFs with an arterial volume flow <50 mL/min were seven times as likely to fail as RAVFs with higher volume flows (OR, 7.0; 95% CI, 2.35-20.87; P < .001).
Conclusions: In this cohort, a radial artery flow rate <50 mL/min was associated with a sevenfold increased risk of FTM in RAVF, which to our knowledge has not been previously reported in the literature. Preoperative ultrasound mapping adds objective assessment in the clinical prediction of AVF FTM.
Resumo:
: High-grade serous ovarian cancer is characterized by genomic instability, with one half of all tumors displaying defects in the important DNA repair pathway of homologous recombination. Given the action of poly(ADP-ribose) polymerase (PARP) inhibitors in targeting tumors with deficiencies in this repair pathway by loss of BRCA1/2, ovarian tumors could be an attractive population for clinical application of this therapy. PARP inhibitors have moved into clinical practice in the past few years, with approval from the Food and Drug Administration (FDA) and European Medicines Agency (EMA) within the past 2 years. The U.S. FDA approval of olaparib applies to fourth line treatment in germline BRCA-mutant ovarian cancer, and European EMA approval to olaparib maintenance in both germline and somatic BRCA-mutant platinum-sensitive ovarian cancer. In order to widen the ovarian cancer patient population that would benefit from PARP inhibitors, predictive biomarkers based on a clear understanding of the mechanism of action are required. Additionally, a better understanding of the toxicity profile is needed if PARP inhibitors are to be used in the curative, rather than the palliative, setting. We reviewed the development of PARP inhibitors in phase I-III clinical trials, including combination trials of PARP inhibitors and chemotherapy/antiangiogenics, the approval for these agents, the mechanisms of resistance, and the outstanding issues, including the development of biomarkers and the rate of long-term hematologic toxicities with these agents.
IMPLICATIONS FOR PRACTICE: The poly(ADP-ribose) polymerase (PARP) inhibitor olaparib has recently received approval from the Food and Drug Administration (FDA) and European Medicines Agency (EMA), with a second agent (rucaparib) likely to be approved in the near future. However, the patient population with potential benefit from PARP inhibitors is likely wider than that of germline BRCA mutation-associated disease, and biomarkers are in development to enable the selection of patients with the potential for clinical benefit from these agents. Questions remain regarding the toxicities of PARP inhibitors, limiting the use of these agents in the prophylactic or adjuvant setting until more information is available. The indications for olaparib as indicated by the FDA and EMA are reviewed.
Resumo:
The objective was to identify determinants of uptake and maintenance of active school travel (AST) over 4 years in children aged 9 at baseline. Data from wave 1 (n=8502) and 2 (n=7479) of the Growing Up in Ireland study were analysed. At 9- and 13-years 25% and 20% engaged in AST. Children were more likely to maintain or take-up AST if they lived in an urban area. Change in distance to school influenced both maintenance and adoption of AST, with a negative impact seen for increased distance between 9 and 13 years and a positive impact seen for decreased distance. Some factors which predict uptake and maintenance of AST are modifiable and can inform intervention development.
Resumo:
A dor é uma experiência perceptualmente complexa, influenciada por um conjunto variado de fatores biológicos e também psicossociais. A sua vivência varia de pessoa para pessoa, havendo diferentes níveis de impacto no funcionamento emocional, interpessoal, motivacional e físico. A dor sexual, mais conhecida por dispareunia e vaginismo, é uma problemática de natureza habitualmente crónica que afeta muitas mulheres. Apesar de ser um importante alvo de estudo nas últimas décadas, e apesar do impacto que tem nas vidas de muitas mulheres, é ainda uma temática pouco abordada junto dos profissionais de saúde, sendo igualmente difícil a determinação da sua causa e respetivo tratamento. A sua concetualização tem sido um dos principais alvos de discussão entre investigadores e clínicos, havendo quem defenda que a mesma deve ser considerada, ou como uma perturbação de dor, ou como uma disfunção sexual. Contudo, mesmo com um crescimento significativo da literatura, não existem ainda dados que clarifiquem o papel que determinadas variáveis psicossociais exercem no desenvolvimento e manutenção da dor sexual e que forma estas aproximam, ou distanciam, este quadro clínico da dor crónica e de outras disfunções sexuais. Neste contexto, o objetivo do presente estudo consistiu em avaliar a influência do Mindfulness, do afeto-traço, dos pensamentos automáticos, das crenças sexuais, da perceção, vigilância e catastrofização face à dor, da perceção da resposta do outro significativo à dor, da autoestima, da autoestima sexual, do ajustamento diádico e do funcionamento sexual em mulheres com dor sexual, comparando-as com três grupos específicos: mulheres com dor crónica, mulheres com outras dificuldades sexuais e mulheres da população geral, sem nenhuma destas dificuldades. Por outro lado, foi avaliada a capacidade preditiva de cada uma destas variáveis psicossociais na intensidade da dor em mulheres que sofrem de dor sexual e dor crónica. Um total de 1233 mulheres colaboraram no presente estudo: 371 mulheres com dor sexual, 245 mulheres com dor crónica, 94 mulheres com disfunção sexual e 523 mulheres da população geral. As participantes responderam a um conjunto de questionários que foram disponibilizados através de um link online e que avaliaram cada uma das dimensões em estudo. Os resultados mostraram que as mulheres com dor sexual e disfunção sexual apresentaram uma menor capacidade para ser mindful, mais pensamentos automáticos negativos de fracasso/desistência, uma maior escassez de pensamentos eróticos, uma menor autoestima e autoestima sexual e uma menor qualidade do ajustamento diádico e funcionamento sexual, quando comparadas com as mulheres com dor crónica e da população geral. Por outro lado, as mulheres com dor sexual e dor crónica apresentaram maiores níveis de perceção, vigilância e catastrofização face à dor, quando comparadas com as mulheres com disfunção sexual e da população geral. Ao nível da perceção da reposta do outro significativo, as mulheres com dor sexual apresentaram significativamente uma menor perceção de respostas solícitas que as mulheres com dor crónica e da população geral. Não foram encontradas diferenças entre os grupos ao nível do afeto-traço e crenças sexuais disfuncionais. No que diz respeito à intensidade da dor nas mulheres com dor sexual, emergiram como preditores significativos os pensamentos de fracasso, as crenças sexuais de desejo sexual como pecado, a magnificação e o desânimo face à dor, a atenção à dor, a perceção de resposta de punição do outro significativo, o ajustamento diádico, a autoestima e a autoestima sexual. Em relação ao grupo com dor crónica, surgiram como preditores significativos o afeto negativo, o desânimo face à dor, a atenção à dor e a perceção de resposta de punição do outro significativo. Uma análise conjunta de todos estes preditores para cada um dos grupos, demonstrou que a perceção da resposta de punição da parte de outro significativo se constituiu como o melhor preditor da intensidade da dor nas mulheres com dor sexual, enquanto que o desânimo face à dor se mostrou como o mais significativo nas mulheres com dor crónica. De uma forma geral, os resultados demonstraram a importância das diferentes variáveis psicossociais na vivência da dor sexual e na respetiva intensidade da dor. Revelaram ainda que a dor sexual apresenta aspetos em comum, quer com a dor crónica, principalmente ao nível da relação com a dor, quer com outras disfunções sexuais, nomeadamente em termos cognitivos e relacionais. O presente estudo vem assim reforçar a ideia de que este é um quadro clínico multidimensional e complexo, trazendo consigo importantes implicações ao nível da sua concetualização, avaliação e tratamento.
Resumo:
A multivariable predictive controller was implemented to regulate the air temperature, humidity and CO2 concentration for a greenhouse located in the north of Portugal. The controller outputs are computed in order to optimise the future behaviour of the greenhouse environment, concerning the set-point accuracy and the minimization of energy inputs.
Resumo:
In this paper a parallel implementation of an Adaprtive Generalized Predictive Control (AGPC) algorithm is presented. Since the AGPC algorithm needs to be fed with knowledge of the plant transfer function, the parallelization of a standard Recursive Least Squares (RLS) estimator and a GPC predictor is discussed here.